RGC

Regencell Bioscience Holdings Ltd

NASDAQ: RGC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$7.27

-2.55% today

Updated 2026-10-28

Market cap

$3.80B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.02

Dividend yield

—

52W range

$5 – $69

Volume

0.3M

Market cap

$3.80B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.02

Dividend yield

—

52W range

$5 – $69

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.5

Quality

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

0.7

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →271 stocks currently score above 75

Price targets

Analyst target

—

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

+ Debt/equity 0.02x — low leverage

Risks

- Piotroski 2/9 — weak financial health

- Altman Z 0.72 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-5.10M

Key financials

Revenue Net Income Free Cash Flow

Metric	2023	2024	2025	2026	TTM
Revenue	$0.00	$0.00	—	$0.00	—
Net income	$-5.87M	$-4.30M	$-3.58M	$-11.70M	$-6.38M
EPS	—	—	—	—	$-0.02
Free cash flow	$-4.99M	$-4.01M	$-3.27M	$-7.70M	$-5.10M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
RGC	$3.80B	19	4.3	3.0	5.0	6.5	—	Avoid
LLY	$1.12T	76	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$615.87B	57	4.7	8.5	2.7	5.5	-83.05%	Buy
ABBV	$504.37B	73	6.7	8.5	4.0	5.0	-86.73%	Strong Buy
UNH	$360.32B	62	6.7	6.0	4.7	5.5	-25.92%	Buy
MRK	$360.08B	36	4.0	4.5	2.0	5.0	-73.68%	Hold

Smart narrative

Regencell Bioscience Holdings Ltd trades at $7.27. Our Smart Value Score of 19/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 0.72, it sits in the distress.

Frequently asked questions

What is Regencell Bioscience Holdings Ltd's stock price?

Regencell Bioscience Holdings Ltd (RGC) trades at $7.27.

Is Regencell Bioscience Holdings Ltd overvalued?

Regencell Bioscience Holdings Ltd carries a Smart Value Score of 19/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

Altman Z-Score?

Regencell Bioscience Holdings Ltd's Altman Z-Score is 0.72, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.regencellbioscience.com

Quick metrics

P/S ratio—

ROE-806.06%

Beta1.17

50D MA$6.68

200D MA$17.96

Shares out0.50B

Float0.06B

Short ratio—

Avg volume0.3M

Performance

1 week-15.83%

1 month-26.86%

3 months-15.51%

YTD-4.81%

1 year—

3 years—

5 years—

Compare

RGC vs LLY →RGC vs JNJ →RGC vs ABBV →Stock screener →